Several other HHS regulations and policies apply to awards under this part. These include but are not necessarily limited to:

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

42 CFR part 50, subpart A—Responsibility of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science42 CFR part 50, subpart D—Public Health Service grant appeals procedure42 CFR part 50, subpart F—Responsibility of applicants for promoting objectivity in research for which PHS funding is sought42 CFR part 52h—Scientific peer review of research grant applications and research and development contract projects45 CFR part 16—Procedures of the Departmental Grant Appeals Board45 CFR part 46—Protection of human subjects45 CFR part 75—Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards45 CFR part 76—Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants)45 CFR part 80—Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services effectuation of title VI of the Civil Rights Act of 196445 CFR part 81—Practice and procedure for hearings under part 80 of this title45 CFR part 84—Nondiscrimination on the basis of handicap in programs and activities receiving Federal financial assistance45 CFR part 86—Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance45 CFR part 91—Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance45 CFR part 93—New restrictions on lobbying59 FR 14508 (March 28, 1994)—NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical ResearchNote:

This policy is subject to change, and interested persons should contact the Office of Research on Women’s Health, NIH, Room 201, Building 1, MSC 0161, Bethesda, MD 20892-0161 (301-402-1770; not a toll-free number) to obtain references to the current version and any amendments.

59 FR 34496 (July 5, 1994)—NIH Guidelines for Research Involving Recombinant DNA Molecules.Note:

This policy is subject to change, and interested persons should contact the Office of Recombinant DNA Activities, NIH, Suite 323, 6000 Executive Boulevard, MSC 7010, Bethesda, MD 20892-7010 (301-496-9838; not a toll-free number) to obtain references to the current version and any amendments.]

“PHS Grants Policy Statement,” DHHS Publication No. (OASH) 94-50,000 (Revised April 1, 1994), as amended by Addendum, dated January 24, 1995.

Note:

This policy is subject to change, and interested persons should contact the Extramural Outreach and Information Resources Office (EOIRO), Office of Extramural Research, 6701 Rockledge Drive, Room 6208, MSC 7910, Bethesda, MD 20892-7910 (301-435-0714; not a toll-free number) to obtain references to the current version and any amendments. Information may also be obtained by contacting the EOIRO via its e-mail address (asknih@odrockm1.od.nih.gov) and by browsing the NIH Home Page site on the World Wide Web (http://www.nih.gov).]

“Public Health service Policy on Humane Care and Use of Laboratory animals,” Office for Protection from Research Risks, HIH (Revised September 1986).

Note:

This policy is subject to change, and interested persons should contact the Office for Protection for Research Risks, NIH, Suite 3B01, 6100 Executive Boulevard, MSC 7507, Rockville, MD 20852-7507 (301-496-7005; not a toll-free number) to obtain references to the current version and any amendments.]

[61 FR 55114, Oct. 24, 1996, as amended at 81 FR 3010, Jan. 20, 2016]